Clinical Utility of a Fully Automated Microsatellite Instability Test with Minimal Hands-on Time
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Microsatellite instability (MSI) analysis is becoming increasingly important in many types of tumor including colorectal cancer (CRC). The commonly used MSI tests are either time-consuming or labor-intensive. A fully automated MSI test, the Idylla MSI assay, has recently been introduced. However, its diagnostic performance has not been extensively validated in clinical CRC samples. Methods: We evaluated 133 samples whose MSI status had been rigorously validated by standard polymerase chain reaction (PCR), clinical nextgeneration sequencing (NGS) cancer panel test, or both. We evaluated the diagnostic performance of the Idylla MSI assay in terms of sensitivity, specificity, and positive and negative predictive values, as well as various sample requirements, such as minimum tumor purity and the quality of paraffin blocks. Results: Compared with the gold standard results confirmed through both PCR MSI test and NGS, the Idylla MSI assay showed 99.05% accuracy (104/105), 100% sensitivity (11/11), 98.94% specificity (93/94), 91.67% positive predictive value (11/12), and 100% negative predictive value (93/93). In addition, the Idylla MSI assay did not require macro-dissection in most samples and reliably detected MSI-high in samples with approximately 10% tumor purity. The total turnaround time was about 150 minutes and the hands-on time was less than 2 minutes. Conclusions: The Idylla MSI assay shows good diagnostic performance that is sufficient for its implementation in the clinic to determine the MSI status of at least the CRC samples. In addition, the fully automated procedure requires only a few slices of formalin-fixed paraffin-embedded tissue and might greatly save time and labor.
Abstract
Background: Microsatellite instability (MSI) analysis is becoming increasingly important in many types of tumor including colorectal cancer (CRC). The commonly used MSI tests are either time-consuming or labor-intensive. A fully automated MSI test, the Idylla MSI assay, has recently been introduced. However, its diagnostic performance has not been extensively validated in clinical CRC samples. Methods: We evaluated 133 samples whose MSI status had been rigorously validated by standard polymerase chain reaction (PCR), clinical nextgeneration sequencing (NGS) cancer panel test, or both. We evaluated the diagnostic performance of the Idylla MSI assay in terms of sensitivity, specificity, and positive and negative predictive values, as well as various sample requirements, such as minimum tumor purity and the quality of paraffin blocks. Results: Compared with the gold standard results confirmed through both PCR MSI test and NGS, the Idylla MSI assay showed 99.05% accuracy (104/105), 100% sensitivity (11/11), 98.94% specificity (93/94), 91.67% positive predictive value (11/12), and 100% negative predictive value (93/93). In addition, the Idylla MSI assay did not require macro-dissection in most samples and reliably detected MSI-high in samples with approximately 10% tumor purity. The total turnaround time was about 150 minutes and the hands-on time was less than 2 minutes. Conclusions: The Idylla MSI assay shows good diagnostic performance that is sufficient for its implementation in the clinic to determine the MSI status of at least the CRC samples. In addition, the fully automated procedure requires only a few slices of formalin-fixed paraffin-embedded tissue and might greatly save time and labor.
참고문헌 (11)
- Ryan E, "The current value of determining the mismatch repair status of colorectal cancer : a rationale for routine testing", Crit Rev Oncol Hematol, 116, pp.38~57 (2017)
- Shi C, "Molecular testing in colorectal cancer : diagnosis of Lynch syndrome and personalized cancer medicine", Am J Clin Pathol, 137, pp.847~859 (2012)
- Cunningham JM, "Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability", Cancer Res, 58, pp.3455~3460 (1998)
- Battaglin F, "Microsatellite instability in colorectal cancer : overview of its clinical significance and novel perspectives", Clin Adv Hematol Oncol, 16, pp.735~745 (2018)
- Sinicrope FA, "Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes", Gastroenterology, 148, pp.88~99 (2015)
- Le DT, "PD-1 blockade in tumors with mismatch-repair deficiency", N Engl J Med, 372, pp.2509~2520 (2015)
- Kim JE, "Mutation burden and I index for detection of microsatellite instability in colorectal cancer by targeted next-generation sequencing", J Mol Diagn, 21, pp.241~250 (2019)
- Zhu L, "A novel and reliable method to detect microsatellite instability in colorectal cancer by next-generation sequencing", J Mol Diagn, 20, pp.225~231 (2018)
- Laura Samaison, "Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories", Journal of Clinical Pathology, 72(12), pp.830~835 (2019), BMJ[DOI]
- McCarthy AJ, "Heterogenous loss of mismatch repair(MMR)protein expression : a challenge for immunohistochemical interpretation and microsatellite instability(MSI)evaluation", J Pathol Clin Res, 5, pp.115~129 (2019)
- Joost P, "Heterogenous mismatch-repair status in colorectal cancer", Diagn Pathol, 9, pp.126~ (2014)